These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29434389)

  • 1. Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution.
    Wahking RA; Steele RL; Hanners RE; Lockwood SM; Davis KW
    Hosp Pharm; 2018 Feb; 53(1):59-67. PubMed ID: 29434389
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation of a proton pump inhibitor stewardship program.
    Davis KW; Hanners RE; Lockwood SM
    Am J Health Syst Pharm; 2017 Jun; 74(12):932-937. PubMed ID: 28596229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome after Discontinuation of Proton Pump Inhibitors at a Residential Care Site: Quality Improvement Project.
    Lee C; Lo A; Ubhi K; Milewski M
    Can J Hosp Pharm; 2017; 70(3):215-223. PubMed ID: 28680175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential costs of inappropriate use of proton pump inhibitors.
    Ladd AM; Panagopoulos G; Cohen J; Mar N; Graham R
    Am J Med Sci; 2014 Jun; 347(6):446-51. PubMed ID: 24270078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
    McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
    Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.
    Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
    J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a clinical pharmacist-led stewardship program for the appropriate use of acid suppression therapy in older hospitalized patients: a non-randomized controlled study.
    Dumlu HI; Sancar M; Ozdemir A; Okuyan B
    Int J Clin Pharm; 2022 Aug; 44(4):914-921. PubMed ID: 35449351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of an evaluation of the professional practices on the relevance of proton pump inhibitors prescriptions pertinence at the hospital].
    Daumas A; Garros E; Mendizabal H; Gayet S; Bernard F; Bagnères D; Demoux AL; Rossi P; Villani P; Granel B
    Rev Med Interne; 2018 Aug; 39(8):618-626. PubMed ID: 29628172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor discontinuation in long-term care.
    Linsky A; Hermos JA; Lawler EV; Rudolph JL
    J Am Geriatr Soc; 2011 Sep; 59(9):1658-64. PubMed ID: 21883102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the Inappropriate Use of Proton Pump Inhibitors in an Internal Medicine Residency Clinic.
    Boster J; Lowry LE; Bezzant ML; Kuiper B; Surry L
    Cureus; 2020 Jan; 12(1):e6609. PubMed ID: 32064190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.
    Shin S
    Ther Clin Risk Manag; 2015; 11():649-57. PubMed ID: 26005351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults.
    Michal J; Henry T; Street C
    Am J Health Syst Pharm; 2016 Sep; 73(17 Suppl 4):S126-32. PubMed ID: 27543598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing Unnecessary Acid Suppression Use in Hospitalized Patients: A Description of Targeted Strategies Implemented Across a Large Health System.
    Wiggins EH; Burgess LH; Kramer J
    HCA Healthc J Med; 2023; 4(2):125-137. PubMed ID: 37424981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted intervention to curb in-hospital over-prescription of proton pump inhibitors: A longitudinal multicenter quasi-experimental before-and-after study.
    Del Giorno R; Ceschi A; Pironi M; Zasa A; Greco A; Gabutti L
    Eur J Intern Med; 2018 Apr; 50():52-59. PubMed ID: 29274884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-year trends of inappropriate proton pump inhibitor use after hospital discharge.
    Leri F; Ayzenberg M; Voyce SJ; Klein A; Hartz L; Smego RA
    South Med J; 2013 Apr; 106(4):270-3. PubMed ID: 23558416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments.
    Liu L; Yu Y; Fan Q; Wu Z; Li X; Luo H
    BMC Health Serv Res; 2022 Mar; 22(1):417. PubMed ID: 35351121
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.